Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection-Reference-Cited by-同舟云学术

Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection

Published:2022-09 Issue:3 Volume:77 Page:642-652
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Yuen Man-Fung^ORCID,Agarwal Kosh,Ma Xiaoli,Nguyen Tuan T.,Schiff Eugene R.,Hann Hie-Won L.,Dieterich Douglas T.,Nahass Ronald G.^ORCID,Park James S.^ORCID,Chan Sing,Han Steven-Huy B.,Gane Edward J.,Bennett Michael,Alves Katia,Evanchik Marc,Yan Ran,Huang Qi,Lopatin Uri,Colonno Richard^ORCID,Ma Julie,Knox Steven J.,Stamm Luisa M.,Bonacini Maurizio^ORCID,Jacobson Ira M.,Ayoub Walid S.^ORCID,Weilert Frank^ORCID,Ravendhran Natarajan,Ramji Alnoor,Kwo Paul Yien,Elkhashab Magdy,Hassanein Tarek,Bae Ho S.,Lalezari Jacob P.,Fung Scott K.,Sulkowski Mark S.

Publisher

Elsevier BV

Subject

Hepatology

Reference23 articles.

1. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection;J Hepatol,2017

2. EASL clinical practice guidelines: management of chronic hepatitis B virus infection;J Hepatol,2012

3. Chronic hepatitis B virus infection;Seto;Lancet,2018

4. Epidemiology of viral hepatitis and hepatocellular carcinoma;El-Serag;Gastroenterology,2012

5. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial;Chan;Lancet Gastroenterol Hepatol,2016

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multiscale model of the action of a capsid assembly modulator for the treatment of chronic hepatitis B;2024-07-16

2. Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patients;Clinical and Molecular Hepatology;2024-07-01

3. Core protein inhibitors: Opportunities and challenges at the forefront of hepatitis B cure;Clinical and Molecular Hepatology;2024-05-14

4. Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses;JHEP Reports;2024-04

5. Efficacy, safety, and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patients;Clinical and Molecular Hepatology;2024-04-01